|
The Lactational Amenorrhea Method (LAM) was codified at a meeting in Washington, DC in 1989, based on research, program work, and the findings of the Bellagio Consensus Meeting of 1988. It was recently reassessed at a 1995 meeting in Bellagio, and is now considered an appropriate method for programmatic use. LAM has three criteria: Amenorrhea, defined as the absence of the menses. Menses return is defined as the first two sequential days of bleeding or spotting which may occur after two months postpartum. Fully or nearly fully breastfeeding, includes exclusive breastfeeding, almost exclusive breastfeeding, and nearly fully breastfeeding, day and night, on demand by the infant. Efficacy and duration of LAM are enhanced with more intense breastfeeding patterns, especially during the earlier weeks and months. Less than six months postpartum.
The effectiveness of LAM has been demonstrated in clinical trials and in programmatic use. As long as all three criteria are met, the method is about 98%-99% effective (perfect use). If any one of the criteria is unmet, the use of another method which is appropriate for use during breastfeeding should be recommended for continued high pregnancy protection. The method allows deviation from the three criteria without a sudden increase in risk of unplanned pregnancy. Menses return is the least flexible. If a woman is no longer amenorrheic, she cannot use LAM. If a woman has deviated only slightly from the fully or nearly fully breastfeeding criterion, she should be re-counseled about appropriate breastfeeding and may use LAM thereafter if she returns to nearly fully breastfeeding. Small amounts of other food or liquid which do not replace breastfeeds do not have a substantial effect on the woman's fertility. However, lowered frequencies of breastfeeding and regular supplementation to the infant's diet are associated with an increased risk of menses return and a higher probability that ovulation will precede that menses. If an amenorrheic woman is separated from her infant and expresses milk, she may still use LAM. Milk expression by hand or pump may produce sufficient breast stimulation to prevent ovulatory activity. However, her risk of pregnancy is increased to 5 to 6%. LAM can be taught during the prenatal, perinatal, or postnatal periods. Counseling on use of the method is very important. In order for LAM to provide effective protection against pregnancy, the method must be used consistently and correctly with another method started very soon after any of the LAM criteria no longer apply, particularly amenorrhea. It is recommended that the LAM user be provided with another method for self-initiation prior to menses return (See Question 1). There are no medical contraindications to using LAM. However, there are a few conditions under which it is preferable not to breastfeed (e.g., if the mother is using a few specific drugs or has some infectious conditions, or if the infant has certain metabolic disorders). These conditions are discussed more fully in the World Health Organization (WHO) Medical Eligibility Criteria for Contraceptive Use. The follow-up schedule for LAM should be similar to the follow-up schedule used for all temporary methods, with the understanding that before any one of the three criteria will no longer apply, the client should return for counseling and another method of family planning (FP). Citations:
|
||||||||||
|
*To view the file, you need to download and install the free Adobe® Acrobat® Reader software. For the latest version of the Reader software for a variety of platforms, see the Adobe website. |
||||||||||
Any part of Recommendations for Updating Selected Practices in Contraceptive Use may be reproduced or adapted to meet local needs without prior permission from the TG/CWG Secretariat, provided the TG/CWG is acknowledged and the material is made available free of charge or at cost. |
||||||||||
|
| Home | Family Planning |
Maternal & Neonatal
Health | Cervical
Cancer | Related
Health Topics | |
||
|
Website design copyright © 1995-2003 by JHPIEGO Corporation. All rights reserved. Last Updated: 09 Jul 2003 |
||
|
URL: http://www.reproline.jhu.edu/ |